Biphenyl sulfonamide compounds for the treatment of kidney diseases or disorders
NZ792807BActive Publication Date: 2026-09-01TRAVERE THERAPEUTICS INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- NZ792807
- Authority / Receiving Office
- NZ · NZ
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2016-11-16
- Filing Date
- 2017-10-13
- Publication Date
- 2026-09-01
- Estimated Expiration
- 2037-10-13
Smart Images

Figure 1_ABST
Abstract
Methods of treating focal segmental glomerulosclerosis (FSGS) comprising administering a compound having structure (I) or a pharmaceutically acceptable salt thereof, or administering a pharmaceutical composition comprising the compound of structure (I) or pharmaceutically acceptable salt thereof, are provided. The escalating dose is sufficient to baseline reduce urine protein / creatinine above 1.5 g / g by 40% or more.
Need to check novelty before this filing date? Find Prior Art